Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder
This study has been completed.
Study NCT00035802   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received on May 6, 2002.   Last Updated on June 23, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
Affective Disorders, Psychotic
Mood Disorders
Mental Disorders
Additional conditions recognized in this trial
Psychotic Disorders
More general conditions related to this trial
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Topiramate
Placebo
Additional drug interventions recognized in this trial
Central Nervous System Agents
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services